🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a compassionate use study. In addition to providing compassionate u...
Status
Completed
Location
The Center for Diabetes and Endocrine Care
Start Date
2010-11
Trial ID
NCT01371565
Treatments Being Tested
The study treatment period is 15 days in length and includes patients with ...
Status
Completed
Location
Cedars-Sinai Pituitary Center
Start Date
2004-04
Trial ID
NCT00088608
Treatments Being Tested
The study aim was to investigate the efficacy and safety of Osilodrostat in...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-09-24
Trial ID
NCT02468193
Treatments Being Tested
Pathophysiology of Cushing's Syndrome (CS) cardiomyopathy is yet unclear an...
Status
Completed
Location
Elisa Giannetta
Start Date
2016-07
Trial ID
NCT02611258
Treatments Being Tested
Recent studies on health personnel in Colombia have evidenced the considera...
Status
Active Not Recruiting
Location
Instituto Nacional de Salud
Start Date
2022-10-15
Trial ID
NCT05315388
Treatments Being Tested
The purpose of this research study is to determine if treatment with Elagol...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2021-07-06
Trial ID
NCT05038878
Treatments Being Tested
Cushing disease remains a challenging endocrine disorder in which persisten...
Status
Enrolling By Invitation
Location
Faiha Specialized Diabetes, Endocrine, and Metabolism Center
Start Date
2026-05-11
Trial ID
NCT07603466
Treatments Being Tested
The purpose of this study is to find out whether the study drug, metyrapone...
Status
Active Not Recruiting
Location
Mayo Clinic Minnesota
Start Date
2023-12-19
Trial ID
NCT06106295
Treatments Being Tested
The main hypothesis of the HEPACORT study is that upon diagnosis of endogen...
Status
Recruiting
Location
CHRU Nancy
Start Date
2023-10-24
Trial ID
NCT05911620
Treatments Being Tested
Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with ...
Status
Active Not Recruiting
Location
Dept. of Medicine I, University of Wuerzburg
Start Date
2005-09
Trial ID
NCT00457587